MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
CAS No. : 1225021-13-5
MCE 国际站:GLP-1(28-36)amide
产品活性:GLP-1(28-36)amide 是一段 GLP-1 的 C-端九肽,是一种中性内肽酶 (NEP) 裂解 GLP-1 的主要产物。GLP-1(28-36)amide 是一种抗氧化剂,靶向线粒体,抑制线粒体通透性转变 (MPT)。GLP-1(28-36)amide 具有抗糖尿病和心脏保护作用。
研究领域:GPCR/G Protein
作用靶点:GCGR
In Vitro: Different from DPP-IV, NEP, which cleaves GLP-1(7-36)amide or GLP-1(9-36)amide to generate GLP-1(28-36)amide, is widely distributed in endothelial cells, vascular smooth muscle cells, cardiac cells and renal epithelial cells.
GLP-1(28-36)amide (100 nM) treatment on hepatocytes for 24 hours directly modulates mitochondrial oxidative metabolism, such as gluconeogenesis in mitochondria of hepatocytes.
The plasma half-life of GLP-1(28-36)amide is longer in human hepatocytes (t1/2 = 24 min) than that in mouse hepatocytes (t1/2 = 13 min).
In Vivo: The administration of GLP-1(28-36)amide at a rate of 18.5 nmol/kg BW/day for 9 weeks to diet-induced obese mice diminishes the development of hepatic steatosis.
The intraperitoneal injection of 18 nmol/kg GLP-1(28-36)amide once daily for 9 weeks show cytoprotective effect on pancreatic β cells by increasing mass and promoting proliferation in a β-cell injury diabetic mouse model.
An in vivo study in high-fat diet-fed mice indicates that a six-week administration of 18.5 nmol/kg GLP-1(28-36)amide improved hepatic glucose disposal, which is associated with increased cAMP levels and phosphorylation of PKA target.
Administered GLP-1(28-36)amide for 20 min to male C57BL6/J mice (10-12 week old), then isolated hearts underwent 30 min of global ischemia and 40 min of reperfusion, the recovery of left ventricular developed pressure (LVDP) is significantly greater in GLP-1(28-36)amide group compared to vehicle-treated hearts.
相关产品:Bioactive Compound Library Plus | GPCR/G Protein Compound Library | Antioxidant Compound Library | Anti-diabetic Compound Library | Anti-Cardiovascular Disease Compound Library | Peptide Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Dulaglutide | PF-06291874 | Neuropeptide Y, porcine | HAEGTFTSDVS | Glucagon receptor antagonists-5 | Oxyntomodulin TFA | Tirzepatide TFA | Liraglutide | GLP-1R agonist 1 | Exendin-4 acetate | GLP-1(7-37) acetate | Glucagon (1-29), bovine, human, porcine | GPCR modulator-1 | Oxyntomodulin (swine) | VU0453379 | Cotadutide | Elsiglutide | GLP-1 receptor agonist 7 | Exendin(9-39) amide | Glucagon-like peptide 1 (1-37), human TFA | Semaglutide TFA | Retatrutide acetate | GLP-1R modulator C5 | Glucagon (19-29), human | [Des-His1,Glu9]-Glucagon amide TFA | FC382K10W15 TFA | Exendin-3/4 (59-86) | FTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物 | 寡核苷酸 | 抗体 | 点击化学
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介绍:
• MCE (MedChemExpress) 拥有200 多种全球独家化合物库,我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物;
• 50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领;
• 产品种类涵盖各种重组蛋白,多肽,常用试剂盒 ,更有 PROTAC、ADC 等特色产品,广泛应用于新药研发、生命科学等科研项目;
• 提供虚拟筛选,离子通道筛选,代谢组学分析检测分析,药物筛选等专业技术服务;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果;
• 专业团队跟踪最新的制药及生命科学研究进展,为您提供全球最新的活性化合物;
• 与世界各大制药公司及知名科研机构建立了长期的合作。